Cheryl Gault
Equibles does not estimate personal net worth.
Get an email with a short summary when Rapport Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get RAPP alertsAbout Cheryl Gault
Cheryl Gault is recorded as COO at Rapport Therapeutics, Inc. (RAPP). The newest filing on record that lists Cheryl Gault as COO at Rapport Therapeutics, Inc. (RAPP) is dated April 23, 2026. Earlier roles on record: COO at Korsana Biosciences, Inc. (KRSA) until June 27, 2023. Korsana Biosciences, Inc. reported in an 8-K filed June 27, 2023 that Cheryl Gault resigned as Chief Operating Officer. The proxy statement of Korsana Biosciences, Inc. reports total compensation of $644,606 for Cheryl Gault in fiscal 2022, including a base salary of $427,365. Disclosed compensation is on record for 2 fiscal years. Rapport Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Rapport Therapeutics, Inc. includes Abraham N. Ceesay (CEO and Board Member) and Troy Ignelzi (CFO).
“On June 26, 2023, Cheryl Gault announced her resignation as the Chief Operating Officer of Cyclerion Therapeutics, Inc. (the "Company") in order to pursue other opportunities.”
Affiliation history
-
Current
Start not stated–present
Last confirmed April 23, 2026
-
Start not stated–2023-06-27
Company network
Leadership on record at Rapport Therapeutics, Inc.
- Abraham N. Ceesay CEO, Board Member
- Troy Ignelzi CFO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Korsana Biosciences, Inc. (KRSA) | Chief Operating Officer | $427,365 | $644,606 |
| 2021 | Korsana Biosciences, Inc. (KRSA) | Chief Operating Officer | $394,615 | $664,345 |